2nd European Cancer Epigenetics Conference 2017, May 2017, Germany

The 2nd European Cancer Epigenetics Conference is organised by the German Cancer Research Center (DKFZ) Heidelberg and will take place in Heidelberg between May 11-13, 2017.
Cancer epigenetics is developing into one of the most promising and rapidly developing fields in oncology. It reveals mechanisms by which cancer genes are deregulated, provides novel tumour biomarkers to identify and target the cell of origin of a given tumour, and can be exploited to predict cancer risk. Notably, current large-scale cancer genome sequencing efforts have discovered a surprisingly large number of cancer-specific mutations in regulators of the epigenome. The high relevance of epigenetics for cancer goes hand in hand with the development of an increasing number of epigenetic drugs used in cancer therapy. We are inviting researchers to the 2nd symposium to continue exploring this exciting field. The 2017 meeting will be organised into 5 sessions covering the following fields:

  • Mechanisms of Epigenetic Deregulation
  • Epigenetics of Single Cells and Molecules
  • Epigenetic Programming & Epigenetic Plasticity
  • Translational Epigenetics
  • Epigenetic Therapy

Registration deadline: April 15, 2017

More information available here